Detalhe da pesquisa
1.
Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?
Blood
; 2024 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38728380
2.
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany.
Blood
; 140(4): 349-358, 2022 07 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35316325
3.
Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans.
Blood
; 136(12): 1442-1455, 2020 09 17.
Artigo
Inglês
| MEDLINE | ID: mdl-32542357
4.
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT).
Am J Hematol
; 96(1): 40-50, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32944990
5.
The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study.
Biol Blood Marrow Transplant
; 26(12): 2372-2377, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32846200
6.
Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic Advances.
Biol Blood Marrow Transplant
; 23(7): 1193-1202, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-28285082
7.
Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMT.
Haematologica
; 101(9): 1120-7, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27229716
8.
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
Blood
; 117(23): 6063-73, 2011 Jun 09.
Artigo
Inglês
| MEDLINE | ID: mdl-21447828
9.
Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis.
Transplant Cell Ther
; 29(12): 750-756, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37709204
10.
Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study.
Bone Marrow Transplant
; 58(5): 558-566, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36849806
11.
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant
; 57(10): 1556-1563, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35835997
12.
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT.
Bone Marrow Transplant
; 57(1): 23-30, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34599284
13.
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 16(11): 1467-503, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-20699125
14.
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries.
Bone Marrow Transplant
; 55(4): 698-707, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31484992
15.
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries.
Bone Marrow Transplant
; 55(4): 837, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31616063
16.
Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia.
EClinicalMedicine
; 15: 33-41, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31709412
17.
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.
J Clin Oncol
; 37(5): 375-385, 2019 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30403573
18.
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT.
J Hematol Oncol
; 11(1): 40, 2018 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29544522
19.
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet.
Leukemia
; 32(5): 1057-1069, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29515238
20.
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
J Clin Oncol
; 22(14): 2816-25, 2004 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-15254049